Precision medicine is a method of improving patient outcomes by combining clinical and molecular patient data to better understand the disease's biological foundation. Based on specific patient characteristics and unique molecular features of a disease, this approach informs the selection of the most appropriate targeted therapy. Clinical trials are studies in which investigational drugs, devices, or biologics, such as chemotherapy, blood products, or gene treatments, are tested for safety and efficacy in human volunteers. Parallel to the increasing complexity of clinical trials, new frameworks have been built for stronger and faster collaboration between all stakeholders in drug development, including clinicians, pharmaceutical corporations, and regulatory bodies.
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece